Literature DB >> 8380133

Initiators and promoters of lung cancer.

J L Mulshine1, A M Treston, P H Brown, M J Birrer, G L Shaw.   

Abstract

As we expand our knowledge of the initiators and promoters of lung cancer, early detection and intervention strategies show great potential in individuals at high risk, especially smokers and exsmokers. Documented mutations of dominant oncogenes and tumor suppressor genes in human lung cancer cells may represent important steps in the pathogenesis of invasive cancer. The precise molecular events and their sequence that lead to tumor promotion in lung cancer, however, are less well understood. Chemointervention with agents like the retinoids may halt proliferation of cancer cells prior to the development of metastatic competence. Use of anti-growth-factor therapy and peptide hormone antagonists may also have a role in intervention approaches. This paper reviews present understanding of the initiation and promotion of lung cancer, as well as preventive strategies currently proposed for patients at risk.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380133     DOI: 10.1378/chest.103.1_supplement.4s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.

Authors:  Sanhong Yu; Jason L Hornick; Raul S Gonzalez
Journal:  Virchows Arch       Date:  2021-03-17       Impact factor: 4.064

2.  Expression of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors.

Authors:  A Martínez; A M Treston; L Saldise; L M Montuenga; R I Linnoila
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1.

Authors:  Ahmed Abdelbaset-Ismail; Daniel Pedziwiatr; Gabriela Schneider; Jacek Niklinski; Radoslaw Charkiewicz; Marcin Moniuszko; Magda Kucia; Mariusz Z Ratajczak
Journal:  Int J Oncol       Date:  2016-12-02       Impact factor: 5.650

Review 4.  Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer.

Authors:  Marwa Labib Essa; Maged Abdeltawab El-Kemary; Eman Mohammed Ebrahem Saied; Stefano Leporatti; Nemany Abdelhamid Nemany Hanafy
Journal:  Materials (Basel)       Date:  2020-11-27       Impact factor: 3.623

Review 5.  Onco-Preventive and Chemo-Protective Effects of Apple Bioactive Compounds.

Authors:  Linda Nezbedova; Tony McGhie; Mark Christensen; Julian Heyes; Noha Ahmed Nasef; Sunali Mehta
Journal:  Nutrients       Date:  2021-11-11       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.